SCHEMBL874294

SCHEMBL874294

COc1ccc(N2CCNCC2)cc1OC1CCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 3/20 0.53
HTR7 P34969 2/20 0.50
TLR9 Q9NR96 1/20 0.49
TLR7 Q9NYK1 1/20 0.49
HTR1A P08908 2/20 0.49
ADRB1 P08588 4/20 0.49
HTR3E A5X5Y0 2/20 0.49
HTR3B O95264 2/20 0.49
HTR3A P46098 2/20 0.49
HTR3D Q70Z44 2/20 0.49
HTR3C Q8WXA8 2/20 0.49
SIGMAR1 Q99720 1/20 0.49
HTR1D P28221 1/20 0.48
HTR1B P28222 1/20 0.48
PDE4A P27815 2/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
CHRNB2 P17787 2/20 0.47
CHRNA4 P43681 2/20 0.47
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL683235 0.97 PDE4B (0.56) PDE4BHTR7TLR9TLR7HTR1A
SCHEMBL361649 0.85 ADRB1 (0.61) HTR7HTR1AADRB1HTR3EHTR3B
Hydrochloric Acid SCHEMBL2156292 0.84 ADRB1 (0.59) HTR7TLR9TLR7HTR1AADRB1
Hydrochloric Acid SCHEMBL7711565 0.84 ADRB1 (0.59) HTR7TLR9TLR7HTR1AADRB1
SCHEMBL16476067 0.81 PDE4B (0.50) PDE4BPDE4APDE4CPDE4D
SCHEMBL882672 0.80 PDE4B (0.47) PDE4BPDE4APDE4CPDE4D
SCHEMBL10267073 0.79 PDE4B (0.46) PDE4BPDE4APDE4CPDE4D
SCHEMBL4981272 0.78 PDE4B (0.57) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL682890 0.78 PDE4B (0.46) PDE4BTLR9TLR7PDE4APDE4C
SCHEMBL2084595 0.78 PDE4B (0.46) PDE4BTLR9TLR7PDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP disclosed
WO-2012040258-A2 THERAPEUTIC PIPERAZINES HELICON THERAPEUTICS, INC. (US) 2012-03-29 WO disclosed